Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

3 years ago

The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely…

ProSomnus® to Open New Global Headquarters and Manufacturing Center of Excellence, Increasing Manufacturing Capacity and Efficiency

3 years ago

32,219-square-foot facility will quintuple growth and create local jobs All ProSomnus medical devices are made in Pleasanton, CA, USA SAN…

Larimar Therapeutics Announces Oral Presentation at the Upcoming Gordon Research Conference on Mitochondria and Chloroplasts

3 years ago

BALA CYNWYD, Pa., June 28, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…

Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development

3 years ago

Advances lead optimization, first-in-human dose prediction and formulation developmentPRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a…

Accanto Health to Host National Symposium for Eating Disorder Continuing Education in Atlanta, GA

3 years ago

ST. PAUL, Minn., June 28, 2022 (GLOBE NEWSWIRE) -- Registration is now open for Beside and Beyond: The 2022 Accanto…

Rosinbomb™ Market Leader in Professional and Consumer Extraction Products and Technology Announces Another Strategic Patent Grant

3 years ago

Adding to their rich intellectual property portfolio, the granting of the flow channel patent furthers the acceleration of volume production…

BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression

3 years ago

The Company’s Groundbreaking Deep TMS™ Treatment is Included in Israel’s Health Basket of Essential Medical ServicesBURLINGTON, Mass. and JERUSALEM, June…

Merakris CEO To Discuss Dermacyte® Development Program As Part of Advanced Wound Care Summit Panel in July

3 years ago

RESEARCH TRIANGLE PARK, N.C., June 28, 2022 (GLOBE NEWSWIRE) -- About five years ago, the U.S. Food and Drug Administration…

JenaValve Announces Results from First Commercial Trilogy Heart Valve System Implants in Europe

3 years ago

IRVINE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. (“JenaValve” or the “Company”), developer and manufacturer of differentiated…

Araris Biotech AG to Present at the H.C. Wainwright Preclinical Cancer Drug Discovery Virtual Conference

3 years ago

ZURICH, Switzerland, June 28, 2022 (GLOBE NEWSWIRE) -- Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology,…